1	4 Females should be either of non-childbearing potential defined as having undergone surgical sterilization or postmenopausal age 50 and amenorrheic for 12 months or of childbearing potential Females of childbearing potential must have a negative serum Beta Human Chorionic Gonadotropin ?-hCG at Visit|hCG[289,292]|||||||12 months[153,162]||C1141639|340705|340705|chorionic gonadotropin, human
2	1 and a negative urine pregnancy test prior to randomization at Visit 2 Female subjects of childbearing potential must agree to be abstinent or to use at least 1 medically acceptable method of contraception eg a double-barrier method eg condom spermicide condom diaphragm with spermicide IUD or have|spermicide[546,556]||||||||||9969|9969|spermicide
2	1 and a negative urine pregnancy test prior to randomization at Visit 2 Female subjects of childbearing potential must agree to be abstinent or to use at least 1 medically acceptable method of contraception eg a double-barrier method eg condom spermicide condom diaphragm with spermicide IUD or have|spermicide[579,589]||||||||||9969|9969|spermicide
3	a vasectomised partner starting at Visit 1 and throughout the entire study period and for 2 months after the last dose of study drug Those women using hormonal contraceptives must also be using an additional approved method of contraception as described previously starting at Visit 1 and continuing throughout|contraceptives[762,776]|||||||2 months[692,700]|||2815|2815|contraceptives
4	the entire study period and for 2 months after the last dose of study drug It is not required for male subjects to use contraceptive measures based on preclinical toxicology data|contraceptive[1032,1045]|||||||2 months[945,953]|||64078|64078|contraceptive
